Navigation Links
Ranbaxy Gets FDA Approval for Insomnia Drug

Indian drug major Ranbaxy Laboratories Ltd says it has obtained tentative approval from the US Food and Drug Administration to manufacture// and market a drug for insomnia.

The US unit of the company announced Friday that the Office of Generic Drugs, US FDA, has determined the Ranbaxy formulations of Zolpidem Tartrate tablets to be bioequivalent and to have the same therapeutic effect as that of Ambien tablets of Sanofi Aventis US, LLC.

Zolpidem Tartrate tablets are indicated for the short-term treatment of insomnia and related disorders. As per latest data, the total annual market sales for Zolpidem Tartrate tablets were $2.12 billion.

Ranbaxy said the new drug would be manufactured at the company's Ohm Laboratories Inc. facility, based in North Brunswick, New Jersey, USA.

The vice president of sales and marketing of Ranbaxy Pharmaceuticals Inc., USA, Jim Meehan, said that the product would be launched following final approval from the FDA. This would give yet another opportunity for Ranbaxy to expand its product portfolio by offering an affordable generic alternative, he added.

The Jacksonville, Florida-based Ranbaxy Pharmaceuticals Inc. is a wholly owned subsidiary of the company. RPI is engaged in the sale and distribution of generic and branded prescription products in the US healthcare system.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ranbaxy Gets FDA Approval for Insomnia Drug

(Date:8/28/2015)... ... August 28, 2015 , ... Altima ... and diagramming network and data center assets and audio-video devices, recently released Visio ... Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super Micro Computer ...
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... patient loyalty at a low cost. Personalized with practice contact information and logos, ... patients. Dental offices can also incorporate Calendars into seasonal mailings, thank you and ...
(Date:8/28/2015)... ... , ... Mendon, IL, home of the Adams County Fairgrounds, was treated once ... good cause. In its second year, the “Music With A Mission” benefit concert was ... “Mission” of “Music With A Mission” is to raise money to help fund music ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... which is dedicated to distributing health information technology innovation to transform quality and ... Results of the survey will be de-identified and aggregated before being publicly shared ...
Breaking Medicine News(10 mins):Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2
... When a child is born the lives ... centered around the safety,happiness and success of this ... and,days are spent thinking about soccer practice carpools, ... when that future tragically,disappears? Experts from Brookhaven ...
... require intensive care, one expert says , , FRIDAY, Jan. 16 ... women struggling with postpartum depression can be treated effectively by ... two studies find. , Both reports, published in the Jan. ... talk therapy and caring communication can help new mothers deal ...
... Thousands of Catholics will gather in the Basilica of ... an end to abortion at the National Prayer Vigil for ... eve of the 36th anniversary of Roe v. Wade ... - many of them youth from schools around the nation ...
... BALTIMORE, Jan. 16 Lupin Pharmaceuticals, Inc. (LPI) ... for the Company,s Abbreviated New Drug Application (ANDA) ... from the U.S. Food and Drug Administration (USFDA). ... Levetiracetam tablets are the AB-rated generic equivalent of ...
... - During a teleconference on Monday, three ... dual action iron supplement pill with virtually no gastrointestinal ... nutritional benefits from iron to be available without a ... FISSN, CSCS; Curt Behrens, president of P2B Inc. ...
... announces the availability of a specialized search ... health care professionals. The site allows dentistry ... research, equipment specifications, continuing education, and dental ... can find what they are looking for ...
Cached Medicine News:Health News:Overwhelming Grief From Loss of Child Can Cause Substance Abuse in Women 2Health News:Overwhelming Grief From Loss of Child Can Cause Substance Abuse in Women 3Health News:Caring Counseling May Ease Postpartum Depression 2Health News:Caring Counseling May Ease Postpartum Depression 3Health News:National Prayer Vigil for Life Opening Mass 2Health News:Lupin is Granted USFDA Approval for Levetiracetam Tablets 2Health News:Teleconference on Monday, January 19, Announcing New, Innovative Dual Iron Supplement Now Available Over the Counter 2Health News:Includesdental.com Announces Search Engine for Dentists, Hygienists and Oral Health Industry 2
(Date:8/27/2015)... Mass. , Aug. 27, 2015  A ... the KSSTA Knee Journal, compared the Arthrosurface HemiCAP® ... Arthroplasty design, versus an "onlay" design implant for ... similar improvements in function and pain scores, none ... progression of osteoarthritis (OA). However, 53% of the ...
(Date:8/27/2015)... , Aug. 27, 2015 Biosimilars ... (BPC) applauds the U.S. Food and Drug Administration ... distinguishable name in its draft guidance issued today. ... biological products proposes distinguishable names, calling for biological ... an FDA-designated suffix. This proposal reflects the agency,s ...
(Date:8/27/2015)... 2015 According to a new market research ... Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, ... by MarketsandMarkets, the Medical Lifting Sling Market is poised to reach ... at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4